Cytomegalovirus (CMV) is a common chronic herpesvirus found in humans and numerous other mammalian species. In people, chronic viruses like CMV can alter overall health and immunity and pose a serious risk for those with an inadequate immune system. In addition, CMV plays an important role in animal health, and could affect the health of vulnerable populations, like endangered species. Previous studies found a high rate of CMV seropositivity among adult baboons (), and results from our laboratory revealed that baboon CMV (BaCMV) seropositivity was correlated with altered immune cell populations. In the current study, we further characterized BaCMV infection in normal, adult baboons. Analysis of blood samples from baboons (age, 6 to 26 y) revealed a low overall prevalence of detectable of BaCMV DNA, with a higher detection rate in aged baboons (older than 15 y). Furthermore, data suggest that individual baboons maintain similar rates of recurrence and levels of BaCMV shedding in saliva over time. Finally, we evaluated multiple commercially available assays for antihuman CMV IgG and IgM for use with baboon sera. Results of this study will improve our understanding of BaCMV and may be directly relevant to other closely related species.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382043 | PMC |
http://dx.doi.org/10.30802/AALAS-CM-18-000050 | DOI Listing |
PLoS One
December 2024
Centre de Recherche en Psychologie et Neurosciences, UMR7077, Aix-Marseille University, CNRS, Marseille, France.
In humans, simple 2D visual displays of launching events ("Michottean launches") can evoke the impression of causality. Direct launching events are regarded as causal, but similar events with a temporal and/or spatial gap between the movements of the two objects, as non-causal. This ability to distinguish between causal and non-causal events is perceptual in nature and develops early and preverbally in infancy.
View Article and Find Full Text PDFFront Trop Dis
July 2024
PAI Life Sciences, Seattle, WA, United States.
Introduction: Schistosomiasis is a neglected tropical disease that puts over 200 million people at risk, and prevention options are sparse with no approved vaccine. Our vaccine candidate, SchistoShield, is based on an approximately 87 kDa large subunit of calcium activated neutral protease - termed Sm-p80 - combined with a potent TLR4 agonist-based adjuvant. SchistoShield has been shown to prevent disease throughout the parasitic life cycle - including egg, juvenile, and adult worm stages - in numerous animal models up to and including baboons.
View Article and Find Full Text PDFVet Sci
September 2024
Department of Comparative Medicine, The University of Texas MD Anderson Cancer Center, Michale E. Keeling Center for Comparative Medicine and Research, 650 Cool Water Drive, Bastrop, TX 78602, USA.
bioRxiv
September 2024
Department of Anthropology, Stony Brook University, Stony Brook, NY, USA.
J Anat
January 2025
UMR 7194 (Histoire Naturelle de l'Homme Préhistorique), CNRS-Muséum National d'Histoire Naturelle-UPVD, Paris, France.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!